Ahmadi S, Rahimian E, Rahimi S, Zarandi B, Bahraini M, Soleymani M
Biomark Res. 2024; 12(1):137.
PMID: 39538363
PMC: 11565275.
DOI: 10.1186/s40364-024-00676-9.
Biderman B, Likold E, Severina N, Obukhova T, Sudarikov A
Genes (Basel). 2023; 14(2).
PMID: 36833459
PMC: 9957161.
DOI: 10.3390/genes14020532.
Mansouri L, Thorvaldsdottir B, Sutton L, Karakatsoulis G, Meggendorfer M, Parker H
Leukemia. 2022; 37(2):339-347.
PMID: 36566271
PMC: 9898037.
DOI: 10.1038/s41375-022-01802-y.
Pozzo F, Bittolo T, Tissino E, Zucchetto A, Bomben R, Polcik L
Cancers (Basel). 2022; 14(12).
PMID: 35740661
PMC: 9221163.
DOI: 10.3390/cancers14122997.
Afkhami M, Ally F, Pullarkat V, Pillai R
Cancer Treat Res. 2021; 181:17-43.
PMID: 34626353
DOI: 10.1007/978-3-030-78311-2_2.
Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma.
Yamagishi M, Kubokawa M, Kuze Y, Suzuki A, Yokomizo A, Kobayashi S
Nat Commun. 2021; 12(1):4821.
PMID: 34376672
PMC: 8355240.
DOI: 10.1038/s41467-021-25101-9.
From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct.
Gonzalez-Gascon-Y-Marin I, Munoz-Novas C, Rodriguez-Vicente A, Quijada-Alamo M, Hernandez-Sanchez M, Perez-Carretero C
Cancers (Basel). 2021; 13(8).
PMID: 33917885
PMC: 8068228.
DOI: 10.3390/cancers13081782.
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia.
Del Poeta G, Biagi A, Laurenti L, Chiarenza A, Pozzo F, Innocenti I
Haematologica. 2020; 106(9):2345-2353.
PMID: 32732360
PMC: 8409042.
DOI: 10.3324/haematol.2020.251488.
Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse.
Forero-Castro M, Montano A, Robledo C, Garcia de Coca A, Fuster J, de Las Heras N
Diagnostics (Basel). 2020; 10(7).
PMID: 32635531
PMC: 7400270.
DOI: 10.3390/diagnostics10070455.
Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL.
Hubmann R, Schnabl S, Araghi M, Schmidl C, Rendeiro A, Hilgarth M
Cells. 2020; 9(6).
PMID: 32570839
PMC: 7348714.
DOI: 10.3390/cells9061484.
Clinical Value of NOTCH1 Mutations Detection among Chronic Lymphocytic Leukemia Patients.
Aref S, El-Agder M, Salama O, Abouzeid T, Sabry M
Asian Pac J Cancer Prev. 2020; 21(5):1295-1301.
PMID: 32458636
PMC: 7541881.
DOI: 10.31557/APJCP.2020.21.5.1295.
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12.
Autore F, Strati P, Innocenti I, Corrente F, Trentin L, Cortelezzi A
Cancers (Basel). 2019; 11(7).
PMID: 31248056
PMC: 6678692.
DOI: 10.3390/cancers11070896.
The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA.
Wang-Rodriguez J, Yunes A, Phan R, Ma N, Baddoura F, Mosse C
Fed Pract. 2019; 34(Suppl 5):S50-S61.
PMID: 30766310
PMC: 6375472.
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.
Rosati E, Baldoni S, De Falco F, Del Papa B, Dorillo E, Rompietti C
Front Oncol. 2018; 8:229.
PMID: 29998084
PMC: 6030253.
DOI: 10.3389/fonc.2018.00229.
Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review.
Autore F, Strati P, Laurenti L, Ferrajoli A
Haematologica. 2018; 103(6):931-938.
PMID: 29748447
PMC: 6058775.
DOI: 10.3324/haematol.2017.186684.
The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.
Gaidano G, Rossi D
Hematology Am Soc Hematol Educ Program. 2017; 2017(1):329-337.
PMID: 29222275
PMC: 6142556.
DOI: 10.1182/asheducation-2017.1.329.
Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons.
Rodriguez-Vicente A, Bikos V, Hernandez-Sanchez M, Malcikova J, Hernandez-Rivas J, Pospisilova S
Oncotarget. 2017; 8(41):71234-71248.
PMID: 29050359
PMC: 5642634.
DOI: 10.18632/oncotarget.19525.
Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.
Sandoval-Sus J, Chavez J, Dalia S, Naqvi S, Talati C, Nodzon L
Leuk Lymphoma. 2017; 59(1):59-68.
PMID: 28641468
PMC: 7771359.
DOI: 10.1080/10428194.2017.1323271.
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia.
Quijada-Alamo M, Hernandez-Sanchez M, Robledo C, Hernandez-Sanchez J, Benito R, Montano A
J Hematol Oncol. 2017; 10(1):83.
PMID: 28399885
PMC: 5387353.
DOI: 10.1186/s13045-017-0450-y.
A Novel Assay for the Identification of NOTCH1 PEST Domain Mutations in Chronic Lymphocytic Leukemia.
Campregher P, Petroni R, Muto N, Sitnik R, Carvalho F, Bacal N
Biomed Res Int. 2017; 2016:4247908.
PMID: 28074183
PMC: 5198094.
DOI: 10.1155/2016/4247908.
